[ad_1] Novartis agreed to purchase the rights of a drug to treat a skin disease to developers Galapagos NV and MorphoSys AG in a transaction that could reach 1,000 million US dollars …
Read More »
[ad_1] After Invima ordered the removal of several lots of drugs containing the compound valsartan, since it represents a risk for the health of the people the same entity made a call …
Read More »
[ad_1] The National Institute for Food and Drug Monitoring, Invima indicated, following a statement, that following the international identification of a carcinogenic substance the valsartan a drug used by patients hypertension it …
Read More »